X
European Commission ploughs €100 billion into new R&D programme
https://pharmaphorum.com/news/european-commission-rd-programme/
EU
EC to update IP rules to benefit generic exports
The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.
Clinical trial lay summaries: a clearer picture emerges
EC wants pharma to make clinical trial results more patient-friendly.
Diabetes ‘lab-on-chip’ start-up gets €2M EU cash
Money comes from Horizon 2020 fund.
British pharma, biotech reiterate ‘Remain’ support
On the eve of the hugely important referendum, the result is too close to call.
